Hangzhou Yuhong Pharmaceutical Technology
At a glance
- Status
- Operational
- Open positions
- None listed
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2023 | $11M | $44M | Hangzhou Mithril Capital · Hainan Huishengde · Zhejiang Xianju Pharmaceutical · Hangzhou Yulin | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hangzhou Yuhong Pharmaceutical Technology in the Hangzhou ecosystem
The Hangzhou Yuhong Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- HCHangzhou Mithril Capital
- HHHainan Huishengde
Zhejiang Xianju Pharmaceutical- HYHangzhou Yulin
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hangzhou Yuhong Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hangzhou Yuhong Pharmaceutical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.